Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00749385 · ClinicalTrials.gov registry record · Phase 1
A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels
A Phase 1 study, sponsored by POZEN.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT00749385 is a Phase 1 study that has completed, run by POZEN. The registered enrollment target is 40 participants.
The verdict
NCT00749385, a Phase 1 study, has completed, sponsored by POZEN.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
A pharmacokinetic study evaluating naproxen and esomeprazole blood levels in 4 treatments, each containing one or both components.
Interventions
- DRUG PN 400
- DRUG EC naproxen plus EC esomeprazole
- DRUG EC naproxen
- DRUG EC esomeprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2008-08 |
| Est. Completion | 2008-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00749385
The ClinicalTrials.gov registry entry for NCT00749385 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is POZEN, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which PN 400 is the first listed.
NCT00749385 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00749385 about?
NCT00749385 is a clinical study titled "A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels". A pharmacokinetic study evaluating naproxen and esomeprazole blood levels in 4 treatments, each containing one or both components.
What is the current status of trial NCT00749385?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2008-08. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00749385?
The interventions under investigation include: PN 400 (DRUG), EC naproxen plus EC esomeprazole (DRUG), EC naproxen (DRUG), EC esomeprazole (DRUG).
Who is sponsoring clinical trial NCT00749385?
This trial is sponsored by POZEN, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.